BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28177572)

  • 21. Early predictors of functional disability in Guillain-Barré Syndrome.
    Tunç A
    Acta Neurol Belg; 2019 Dec; 119(4):555-559. PubMed ID: 30963477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical prognostic scoring system for Guillain-Barré syndrome.
    van Koningsveld R; Steyerberg EW; Hughes RA; Swan AV; van Doorn PA; Jacobs BC
    Lancet Neurol; 2007 Jul; 6(7):589-94. PubMed ID: 17537676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and epidemiological features of Guillain-Barré syndrome in the Western Balkans.
    Peric S; Milosevic V; Berisavac I; Stojiljkovic O; Beslac-Bumbasirevic L; Marjanovic I; Djuric V; Djordjevic G; Rajic S; Cvijanovic M; Babic M; Dominovic A; Vujovic B; Cukic M; Petrovic M; Toncev G; Komatina N; Martic V; Lavrnic D
    J Peripher Nerv Syst; 2014 Dec; 19(4):317-21. PubMed ID: 25582576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
    Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
    J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome.
    Dornonville de la Cour C; Jakobsen J
    Neurology; 2005 Jan; 64(2):246-53. PubMed ID: 15668421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guillain Barre Syndrome in the elderly: Experience from a tertiary-care hospital in India.
    Nagappa M; Rahul W; Sinha S; Bindu PS; Mathuranath PS; Rao S; Periyavan S; Umamaheshwara Rao GS; Taly AB
    J Clin Neurosci; 2017 Dec; 46():45-49. PubMed ID: 28890042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical characteristics and short-term prognosis in elderly patients with Guillain-Barré syndrome.
    Zhang B; Wu X; Shen D; Li T; Li C; Mao M; Zhang HL; Liu K
    Medicine (Baltimore); 2017 Jan; 96(1):e5848. PubMed ID: 28072747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of a single-center-based early prognostic scoring system for Guillain-Barré syndrome.
    Di X; Wang J; Li L; Liu L
    BMC Neurol; 2023 Mar; 23(1):97. PubMed ID: 36870949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of the international classification of functioning, disability and health to describe patient-reported disability: a comparison of motor neurone disease, Guillain-Barré syndrome and multiple sclerosis in an Australian cohort.
    Ng L; Khan F
    Disabil Rehabil; 2012; 34(4):295-303. PubMed ID: 21988084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barré syndrome: A pilot study.
    Axelsson M; Sjögren M; Andersen O; Blennow K; Zetterberg H; Lycke J
    Acta Neurol Scand; 2018 Aug; 138(2):143-150. PubMed ID: 29624650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
    Altmann P; De Simoni D; Kaider A; Ludwig B; Rath J; Leutmezer F; Zimprich F; Hoeftberger R; Lunn MP; Heslegrave A; Berger T; Zetterberg H; Rommer PS
    J Neuroinflammation; 2020 Mar; 17(1):86. PubMed ID: 32183837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of patients with Guillain-Barré syndrome requiring mechanical ventilation.
    Netto AB; Taly AB; Kulkarni GB; Uma Maheshwara Rao GS; Rao S
    Neurol India; 2011; 59(5):707-11. PubMed ID: 22019655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six-month prospective study of quality of life in Guillain-Barre syndrome.
    Djordjevic G; Stojanov A; Bozovic I; Berisavac I; Arsenijevic M; Lukic Rajic S; Dominovic Kovacevic A; Jovanovic D; Basta I; Peric S
    Acta Neurol Scand; 2020 Mar; 141(3):236-241. PubMed ID: 31705530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guillain-Barré Syndrome, variants & forms fruste: Reclassification with new criteria.
    Hiew FL; Ramlan R; Viswanathan S; Puvanarajah S
    Clin Neurol Neurosurg; 2017 Jul; 158():114-118. PubMed ID: 28514704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyponatraemia in Guillain-Barré syndrome revisited.
    Hiew FL; Winer JB; Rajabally YA
    Acta Neurol Scand; 2016 Apr; 133(4):295-301. PubMed ID: 26184092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What constitutes a 'good' recovery outcome in post-acute Guillain-Barré syndrome? Results of a nationwide survey of post-acute GBS sufferers in the United Kingdom.
    Davidson I; Wilson C; Walton T; Brissenden S; Campbell M; McGowan L
    Eur J Neurol; 2010 May; 17(5):677-83. PubMed ID: 20050884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical predictors of mechanical ventilation in Guillain-Barré syndrome.
    Paul BS; Bhatia R; Prasad K; Padma MV; Tripathi M; Singh MB
    Neurol India; 2012; 60(2):150-3. PubMed ID: 22626694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression.
    Gao Y; Zhang HL; Xin M; Wang D; Zheng N; Wang S; Xu J; Wang Y; Zhu J; Feng J
    Biomed Res Int; 2018; 2018():5703279. PubMed ID: 30013984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting Glucose Levels Correlate with Disease Severity of Guillain-Barré Syndrome.
    Wang Y; Li G; Yang S; Gu X; Li X; Liu M; Wu X; Guan Y; Press R; Zhu J; Zhang HL
    PLoS One; 2015; 10(12):e0145075. PubMed ID: 26684748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.